Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

Shimoga Chemicals

US Class II Ongoing · initiated 2026-05-19

cGMP deviations

Honibe Honey Gummies Melatonin / Honibe Gummie Bees Melatonin Sleep Support

Canada Type II Ongoing · initiated 2026-05-19

Product quality. Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health c…

AbbVie Inc.

US Class III Ongoing · initiated 2026-05-18

Failed Stability Specifications

Eugia US LLC

US Class III Ongoing · initiated 2026-05-18

Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

IntegraDose Compounding Services LLC

US Class II Ongoing · initiated 2026-05-18

Subpotent Drug

PReye LLC

US Class II Ongoing · initiated 2026-05-18

Lack of Assurance of Sterility

PAI Holdings LLC

US Class II Ongoing · initiated 2026-05-15

Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023

PAI Holdings LLC

US Class II Ongoing · initiated 2026-05-15

Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023

PAI Holdings LLC

US Class II Ongoing · initiated 2026-05-15

Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023

PAI Holdings LLC

US Class II Ongoing · initiated 2026-05-15

Does Not Meet USP or OTC Monograph: Product did not meet the Over-the-Counter (OTC) Monograph M023

AVEVA Drug Delivery Systems, Inc.

US Class III Ongoing · initiated 2026-05-14

Failed Impurities/Degradation Specifications: Elevated levels of oxidative-related impurities, exceeding shelf-life specifications during stability testing of i…

Asclemed USA Inc.

US Class II Ongoing · initiated 2026-05-14

CGMP Deviations; presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the FDA acceptable intake limit.

Fresenius Kabi USA, LLC

US Class III Ongoing · initiated 2026-05-14

Failed Impurities/Degradations Specifications

IntegraDose Compounding Services LLC

US Class II Ongoing · initiated 2026-05-12

Subpotent Drug

ANI Pharmaceuticals, Inc.

US Class II Ongoing · initiated 2026-05-12

Defective Container; packets were found to be either empty or partially full.

Spectra Medical Devices, Llc

US Class II Ongoing · initiated 2026-05-12

Lack of Assurance of Sterility

SUN PHARMACEUTICAL INDUSTRIES INC

US Class I Ongoing · initiated 2026-05-12

Presence of Particulate matter: Particulate matter identified as glass.

Haleon US Holdings LLC

US Class II Ongoing · initiated 2026-05-11

Labeling: Not Elsewhere Classified- Incomplete inactive ingredient information on the carton labeling.

Nitrous Oxide whipped cream chargers

Canada Type I Ongoing · initiated 2026-05-11

Unauthorized product. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any heal…

UCB Biosciences Inc.

US Class II Ongoing · initiated 2026-05-08

Lack of Assurance of Sterility

GHK-Cu & BPC-157 powder

Canada Type I Ongoing · initiated 2026-05-07

Product quality. Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health c…

Ascend Laboratories, LLC

US Class II Ongoing · initiated 2026-05-05

Failed Dissolution Specifications: Olmesartan Medoxomil content below specifications

Sagent Pharmaceuticals

US Class III Ongoing · initiated 2026-05-04

Failed Impurities/Degradation Specifications

Amerisource Health Services LLC

US Class III Ongoing · initiated 2026-05-01

Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.

Amerisource Health Services LLC

US Class III Ongoing · initiated 2026-05-01

Cross contamination with other products: API contaminated with trace amounts of Acemetacin API.